What I could tell you is that as a follow-up to the recommendations coming from the OAG audit, there was a recommendation to Health Canada to put in place better oversight of clinical trials. The federal government introduced Division 5, which is clinical trial regulations, in 2001, which put more responsibility on the sponsor in the oversight of clinical trials. The year after that there was a clinical trial site inspection program put in place. So as of 2002, Health Canada has a good clinical practice inspection program running. Some of the changes to Division 5 and inspections were a follow-up to some of the recommendations in that report, recommendations that were specific to Health Canada. I can't speak to the DND side.
On November 3rd, 2016. See this statement in context.